{"id":158,"date":"2018-06-28T11:16:23","date_gmt":"2018-06-28T11:16:23","guid":{"rendered":"http:\/\/milannetconference.com\/?page_id=158"},"modified":"2018-10-16T13:23:49","modified_gmt":"2018-10-16T13:23:49","slug":"abstract-2018","status":"publish","type":"page","link":"https:\/\/milannetconference.com\/?page_id=158","title":{"rendered":"ABSTRACT 2018"},"content":{"rendered":"<p><\/p>\n<p>[vc_row][vc_column width=&#8221;1\/1&#8243;][vc_row_inner][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_single_image media=&#8221;50&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221;][\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][\/vc_row_inner][vc_column_text]<\/p>\n<h1 style=\"text-align: center;\"><strong>P<\/strong><strong>r<\/strong><strong>ogr<\/strong><strong>amma<\/strong><\/h1>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_column_text]<\/p>\n<h2>SESSION 1: STATE OF THE ART<\/h2>\n<h4>CHAIRS: \u00a0<strong>F. DE BRAUD, V. MAZZAFERRO<\/strong><\/h4>\n<p>Discussants:\u00a0<strong>L.\u00a0<\/strong><strong>C<\/strong><strong>a<\/strong><strong>tena,\u00a0<\/strong><strong>M. Fassan, F. Grillo, F. Panzuto, A. Trama<\/strong><\/p>\n<p><strong>09:00-09:20<\/strong><strong>\u00a0\u00a0\u00a0\u00a0<\/strong><a href=\"https:\/\/milannetconference.com\/wp-content\/uploads\/2018\/06\/Disparities-between-survival-data-derived-from-clinical-trials-and-epidemiological-studies_Faivre.pdf\" target=\"_blank\" rel=\"noopener\">Disparities between survival data derived from epidemiological studies and clinical trials\u00a0<strong>Faivre<\/strong><\/a><\/p>\n<p><strong>09:20-09:40\u00a0 \u00a0<\/strong><a href=\"https:\/\/milannetconference.com\/wp-content\/uploads\/2018\/06\/Overview-of-Circulating-Biomarkers_Tiensuu-Janson.pdf\" target=\"_blank\" rel=\"noopener\">Overview of circulating biomarkers in NETs\u00a0<strong>Tiensuu Janson<\/strong><\/a><\/p>\n<p><strong>09:40-10:00\u00a0\u00a0 \u00a0<\/strong>Whole-genome landscape of pNETs \u00a0<strong>A. Scarpa<\/strong><\/p>\n<p><strong>10:00-10:20<\/strong><strong>\u00a0\u00a0\u00a0\u00a0<\/strong><a href=\"https:\/\/milannetconference.com\/wp-content\/uploads\/2018\/06\/New-opportunities-of-molecular-targeted-therapies-and-combined-role-with-immunotherapy_Fazio.pdf\" target=\"_blank\" rel=\"noopener\">New opportunities of molecular targeted therapies, and combined role with immunotherapy\u00a0<strong>N. Fazio<\/strong><\/a><\/p>\n<p><strong>10:20-10:40\u00a0\u00a0 \u00a0<\/strong><a href=\"https:\/\/milannetconference.com\/wp-content\/uploads\/2018\/06\/Current-treatment-of-G3-NENs_Sorbye.pdf\" target=\"_blank\" rel=\"noopener\">Current treatment of G3 NENs\u00a0<strong>Sorbye<\/strong><\/a><\/p>\n<p><strong>10:40-11:00\u00a0 \u00a0<\/strong>Coffee break[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_column_text]<\/p>\n<h2>SESSION 2: CURRENT MEDICAL AND SURGICAL MANAGEMENTS<\/h2>\n<h4>Chairs: \u00a0<strong>M. Falconi, V. Mazzaferro<\/strong><\/h4>\n<p>Discussants: <strong>V<\/strong><strong>. Ambrosini, G. Delconte, S. Massironi, F. Riccardi<\/strong><\/p>\n<p><strong>11:00-11:20<\/strong><strong>\u00a0\u00a0\u00a0\u00a0 <\/strong><a href=\"https:\/\/milannetconference.com\/wp-content\/uploads\/2018\/06\/New-standards-in-endoscopy-in-gastric-duodenal-pancreatic-and-rectal-NETs-_Cintolo.pdf\" target=\"_blank\" rel=\"noopener\">New standards in endoscopy in gastric, duodenal, pancreatic and rectal NETs \u00a0<strong>M. Mutignani<\/strong><\/a><\/p>\n<p><strong>11:20-11:40\u00a0 \u00a0<\/strong><a href=\"https:\/\/milannetconference.com\/wp-content\/uploads\/2018\/06\/Non-Pharmacologic-Liver-Directed-Therapies-in-Hepatic-Metastases-from-NET-_Mazzaferro.pdf\" target=\"_blank\" rel=\"noopener\">Effect of combined therapies for liver metastases: novel \u00a0strategies <strong>V. Mazzaferro<\/strong><\/a><\/p>\n<p><strong>11:40-12:00\u00a0 \u00a0<\/strong>Role of adjuvant and neoadjuvant therapies in NET surgery <strong>M. Falconi<\/strong><\/p>\n<p><strong>12:00-12:20\u00a0 \u00a0<\/strong><a href=\"https:\/\/milannetconference.com\/wp-content\/uploads\/2018\/06\/Theranostics-in-NET-Update-and-Novel-Strategies-_Singh.pdf\" target=\"_blank\" rel=\"noopener\">Theranostics in NET: update and novel \u00a0strategies\u00a0<strong>Singh<\/strong><\/a><\/p>\n<h3><strong>Life Achievement Award<\/strong><\/h3>\n<p>Dedication: <strong>E. Bajetta, S. Artale<\/strong><\/p>\n<p><strong>12:20-12:50\u00a0 \u00a0<\/strong>Award: <strong>R<\/strong><strong>ober<\/strong><strong>to<\/strong><strong> Buzzoni<\/strong><\/p>\n<p><strong>12:50-14:00\u00a0 \u00a0<\/strong><span style=\"color: #e84417;\">Lunch<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_column_text]<\/p>\n<h2>SESSION 3: TUMOR BOARD<\/h2>\n<p>Board coordinators and question makers:\u00a0<strong>Fazio, J. Coppa<\/strong><\/p>\n<h3><strong>14:00-15:00\u00a0 \u00a0<\/strong><strong>Tumor board 1<\/strong><\/h3>\n<p>Participants: <strong>T<\/strong><strong>. Cascella, A. Faggiano, M. Milione, S. Pusceddu, C. Sposito, A. Versari<\/strong><\/p>\n<ul>\n<li>Analogues and hypoglycemic drugs<\/li>\n<li>Recurrence post OLT<\/li>\n<li>Immunotherapy<\/li>\n<\/ul>\n<h3><strong>15:00-16:00\u00a0 \u00a0<\/strong><strong>Tumor board 2<\/strong><\/h3>\n<p>Participants: <strong>R<\/strong><strong>. Baldelli, M. Bongini, M. Maccauro,\u00a0<\/strong><strong>M<\/strong><strong>. Milione, S. Partelli, N. Prinzi, F. Spada, C. Spreafico<\/strong><\/p>\n<ul>\n<li>Small pNET<\/li>\n<li>MEN II<\/li>\n<li>Combined therapies: PRRT and SIRT<\/li>\n<\/ul>\n<p><strong>16:00-16:30\u00a0 \u00a0<\/strong><span style=\"color: #e74415;\">Coffee break<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_column_text]<\/p>\n<h2>SESSION 4: QUALITY OF LIFE<\/h2>\n<p>Chairs: \u00a0<strong>C. Carnaghi, D. Conte<\/strong><\/p>\n<p><strong>16:30-16:45<\/strong><strong>\u00a0\u00a0\u00a0\u00a0 <\/strong>Quality \u00a0of life and chronicity in NET patients management <strong>F. Roila<\/strong><\/p>\n<p><strong>16:45-17:00\u00a0 \u00a0<\/strong>Have we got \u00a0specific indicators for the \u00a0electronic patient report outcomes (EPROs)?\u00a0<strong>Bhoori, J. Coppa<\/strong><\/p>\n<p><strong>17:00-17:30\u00a0 \u00a0<\/strong>Patient\u2019s perspective on quality of life in NET: voting session <strong>S. Bhoori, J. Coppa, M. Guglielmo<\/strong><\/p>\n<p><strong>17:30-17:45\u00a0 \u00a0<\/strong><span style=\"color: #e74415;\">Take-home messages and closure<\/span>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column width=&#8221;1\/1&#8243;][vc_row_inner][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_single_image media=&#8221;50&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221;][\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][\/vc_row_inner][vc_column_text] Programma [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_column_text] SESSION 1: STATE OF THE ART CHAIRS: \u00a0F. DE [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/pages\/158"}],"collection":[{"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/milannetconference.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=158"}],"version-history":[{"count":18,"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/pages\/158\/revisions"}],"predecessor-version":[{"id":223,"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/pages\/158\/revisions\/223"}],"wp:attachment":[{"href":"https:\/\/milannetconference.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}